Application 007413
- Type
- NDA
- Sponsor
- PHARMACIA AND UPJOHN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PROTAMINE SULFATE | PROTAMINE SULFATE | INJECTABLE;INJECTION | 50MG/VIAL | No | No |
| 002 | PROTAMINE SULFATE | PROTAMINE SULFATE | INJECTABLE;INJECTION | 250MG/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N007413-001 | PROTAMINE SULFATE | PROTAMINE SULFATE | 50MG/VIAL | POWDER / INTRAVENOUS | Approved before 1982 | ||
| N007413-002 | PROTAMINE SULFATE | PROTAMINE SULFATE | 250MG/VIAL | POWDER / INTRAVENOUS | 1984-08-02 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N007413-001 | PROTAMINE SULFATE | 50MG/VIAL | INJECTABLE / INJECTION | Approved before 1982 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N007413-002 | PROTAMINE SULFATE | 250MG/VIAL | INJECTABLE / INJECTION | 1984-08-02 | 3a93d1ddd44b… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | c76876da-b9a8-45d0-9278-7df3288d3a06 | 2025-04-29 | Boxed warning, Warnings, Adverse reactions | Protamine Sulfate PROTAMINE SULFATE |
| Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | e1964129-33f4-4e4e-86e3-8e6a4e65bd83 | 2025-02-05 | Boxed warning, Warnings, Adverse reactions | Protamine Sulfate PROTAMINE SULFATE |
| Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | 7a31fc4c-579f-45cc-9559-39cfad9a57b3 | 2024-03-18 | Boxed warning, Warnings, Adverse reactions | Protamine Sulfate PROTAMINE SULFATE |
| PROTAMINE SULFATE | PROTAMINE SULFATE | HF Acquisition Co LLC, DBA HealthFirst | 94d4f57f-940e-c0a8-e053-2a95a90ae3af | 2024-01-22 | Boxed warning, Warnings, Adverse reactions | PROTAMINE SULFATE PROTAMINE SULFATE |
| Protamine Sulfate | PROTAMINE SULFATE | Fresenius Kabi USA, LLC | 8df0a819-9e1a-44ce-97a6-3ea82c867d44 | 2024-01-18 | Boxed warning, Warnings, Adverse reactions | Protamine Sulfate PROTAMINE SULFATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.